Alliance A071401: Phase II trial of FAK inhibition in meningiomas with somatic NF2 mutations.

Authors

Priscilla K. Brastianos
Erin Twohy
Elizabeth Robins Gerstner
Timothy J. Kaufmann
A John Iafrate
Suriya A. Jeyapalan
David Eric Piccioni
Andrew B. Lassman
Camilo E. Fadul
David Schiff
Jennie Webster Taylor
Sajeel A. Chowdhary
Thomas J. Kaley
Tara Morrison MD, Lehigh Valley Health NetworkFollow
Priya Kumthekar
Susan GeyerFollow
Daniel P. Cahill
Sandro Santagata
Frederick G. Barker
Evanthia Galanis

Publication/Presentation Date

5-2020

Published In/Presented At

Brastianos, P., Twohy, E., Gerstner, E., Kaufmann, T., Iafrate, A. J., Jeyapalam, S., Piccioni, D., Lassman, A., Fadul, C., Schiff, D., Webster Taylor, J., Chowdhary, S., Kaley, T., Morrison, T., Kumthekar, P., Geyer, S., Cahill, D., Santagata, S., Barker, F., & Galanis, E. (2020, May).Alliance A071401: Phase II trial of FAK inhibition in meningiomas with somatic NF2 mutations. Presentation presented at ASCO 2020 Annual Meeting, Virtual.

Disciplines

Medicine and Health Sciences

Department(s)

Department of Medicine, Hematology-Medical Oncology Division, Department of Medicine Faculty

Document Type

Presentation